A Prospective Phase 2 Study To Assess Minimal Residual Disease After Ixazomib, Lenalidomide And Dexamethasone Treatment For Newly Diagnosed Transplant Eligible Multiple Myeloma PatientsRaija Helena Silvennoinen,Anders Waage,Valdas Peceliunas,Fredrik Schjesvold,Pekka Anttila,Marjaana Säily,Mervi Putkonen,Kristina Carlson,Einar Haukaas,Marja Sankelo,Anu Partanen,Damian L. Szatkowski,Markus Hansson, Anu Marttila,Lucia Ahlberg,Per Axelsson,Birgitta Lauri, Maija Helena Mikkola, Conny Karlsson, Johanna Abelsson,Erik Ahlstrand,Anu Sikiö,Monika Klimkowska,Reda Matuzeviciene,Mona Hoysaeter Fenstad, Sorella Ilveskero,Hareth NahiBLOOD(2020)引用 3|浏览39暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要